Hangzhou AGS MedTech Co., Ltd.

SHSE:688581 Stock Report

Market Cap: CN¥4.8b

HangzhouS MedTech Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Cheng Zhang

Chief executive officer

CN¥3.3m

Total compensation

CEO salary percentagen/a
CEO tenure12.9yrs
CEO ownership40.1%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

An Intrinsic Calculation For Hangzhou AGS MedTech Co., Ltd. (SHSE:688581) Suggests It's 43% Undervalued

Oct 25
An Intrinsic Calculation For Hangzhou AGS MedTech Co., Ltd. (SHSE:688581) Suggests It's 43% Undervalued

There May Be Underlying Issues With The Quality Of HangzhouS MedTech's (SHSE:688581) Earnings

Apr 29
There May Be Underlying Issues With The Quality Of HangzhouS MedTech's (SHSE:688581) Earnings

Hangzhou AGS MedTech Co., Ltd. (SHSE:688581) Looks Inexpensive But Perhaps Not Attractive Enough

Apr 24
Hangzhou AGS MedTech Co., Ltd. (SHSE:688581) Looks Inexpensive But Perhaps Not Attractive Enough

CEO

Cheng Zhang (54 yo)

12.9yrs

Tenure

CN¥3,299,900

Compensation

Mr. Cheng Zhang is Chairman & General Manager of Hangzhou AGS MedTech Co., Ltd. since December 2011.